Marex Group’s Avidity Biosciences RNAM Stock Holding History

Marex Group’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,371	Closed	-$243K	–	1228
2025 Q4	$243K	Sell	3,371 -48,629	-94%	-$3.14M	﹤0.01%	782
2025 Q3	$2.27M	Buy	+52,000	New	+$2.1M	0.02%	251
2025 Q2	–	Sell	-7,000	Closed	-$207K	–	882
2025 Q1	$207K	Hold	7,000	–	–	﹤0.01%	572
2024 Q4	$204K	Sell	7,000 -2,900	-29%	-$121K	﹤0.01%	549
2024 Q3	$455K	Hold	9,900	–	–	0.01%	305
2024 Q2	$404K	Buy	+9,900	New	+$284K	0.01%	344

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Marex Group's RNAM Position: Q1 2026 in Review

Marex Group sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 3,371 shares — an estimated $243K sold.

Marex Group first reported a position in RNAM in Q2 2024 and held it in 6 quarters. The position peaked at $2.27M in Q3 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Marex Group reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Marex Group sold 3,371 Avidity Biosciences shares in Q1 2026, an estimated $243K.
Marex Group first reported a position in Avidity Biosciences in Q2 2024 and held it in 6 quarters.
Marex Group's Avidity Biosciences position peaked at $2.27M in Q3 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.